$CUE – Cue Biopharma Inc. Took a position at .9
Post# of 29805
(Total Views: 49)
Posted On: 07/21/2025 2:06:41 PM
$CUE – Cue Biopharma Inc.
Took a position at .90
Due Diligence: Immunotherapy company targeting cancer and autoimmune diseases.
Why It Should Run: Recent insider buying and strong preclinical data.
Target Price: $1.20
Took a position at .90
Due Diligence: Immunotherapy company targeting cancer and autoimmune diseases.
Why It Should Run: Recent insider buying and strong preclinical data.
Target Price: $1.20
(0)
(0)